-
1Academic Journal
Authors: E. A. Vishneva, L. S. Namazova-Baranova, A. A. Alekseeva, L. R. Selimzyanova, J. G. Levina, K. E. Efendieva, E. A. Dobrynina, Е. А. Вишнёва, Л. С. Намазова-Баранова, А. А. Алексеева, Ю. Г. Селимзянова, Ю. Г. Левина, К. Е. Эфендиева, Е. А. Добрынина
Source: Pediatric pharmacology; Том 13, № 4 (2016); 404-408 ; Педиатрическая фармакология; Том 13, № 4 (2016); 404-408 ; 2500-3089 ; 1727-5776
Subject Terms: дети, allergy pathogenetic therapy, immune tolerance induction and children, сублингвальная аллергенспецифическая иммунотерапия, патогенетическая терапия аллергии, индукция иммунной толерантности
File Description: application/pdf
Relation: https://www.pedpharma.ru/jour/article/view/1450/819; Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136(3): 556–568. doi:10.1016/j.jaci.2015.04.047.; Pitsios C, Demoly P, Bilo MB, et al. Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy. 2015;70(8):897–909. doi:10.1111/all.12638.; Jutel M, Akdis CA. Immunological mechanisms of allergenspecific immunotherapy. Allergy. 2011;66(6):725–732. doi:10.1111/j.1398-9995.2011.02589.x.; Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol. 2014;133(3):621–631. doi:10.1016/j.jaci.2013.12.1088.; Canonica GW, Ansotegui IJ, Pawankar R, et al. A WAO — ARIA — GA(2)LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013;6(1):17. doi:10.1186/1939-4551-6-17.; Sastre J. Molecular diagnosis in allergy. Clin Exp Allergy. 2010; 40(10):1442–1460. doi:10.1111/j.1365-2222.2010.03585.x.; Borres MP, Ebisawa M, Eigenmann PA. Use of allergen components begins a new era in pediatric allergology. Pediatr Allergy Immunol. 2011;22(5):454–461. doi:10.1111/j.1399-3038.2011.01197.x.; Shreffler WG. Microarrayed recombinant allergens for diagnostic testing. J Allergy Clin Immunol. 2011;127(4):843–849; quiz 850–841. doi:10.1016/j.jaci.2011.02.011.; Weber RW. Cross-reactivity of pollen allergens: impact on allergen immunotherapy. Ann Allergy Asthma Immunol. 2007;99(3): 203–212. doi:10.1016/S1081-1206(10)60654-0.; Santos A, Van Ree R. Profilins: mimickers of allergy or relevant allergens? Int Arch Allergy Immunol. 2011;155(3):191-204. doi:10.1159/000321178.; Sastre J, Landivar ME, Ruiz-Garcia M, et al. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy. 2012;67(5):709–711. doi:10.1111/j.1398-9995.2012.02808.x.; Calderon MA, Cox L, Casale TB, et al. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol. 2012;129(4):929–934. doi:10.1016/j.jaci.2011.11.019.; Passalacqua G, Nowak-Wegrzyn A, Canonica GW. Local side effects of sublingual and oral immunotherapy. J Allergy Clin Immunol Pract. Forthcoming 2016. doi:10.1016/j.jaip.2016.06.020.; Passalacqua G, Baena-Cagnani CE, Bousquet J, et al. Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J Allergy Clin Immunol. 2013;132(1):93–98. doi:10.1016/j.jaci.2013.03.039.; Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010;125(3):569–574.e7. doi:10.1016/j.jaci.2009.10.060.; Coop CA, Tankersley MS. Patient perceptions regarding local reactions from allergen immunotherapy injections. Ann Allergy Asthma Immunol. 2008;101(1):96–100. doi:10.1016/S1081-1206(10)60841-1.; Kelso JM. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction. Ann Allergy Asthma Immunol. 2004;92(2):225–227. doi:10.1016/S1081-1206(10)61551-7.; Tankersley MS, Butler KK, Butler WK, Goetz DW. Local reactions during allergen immunotherapy do not require dose adjustment. J Allergy Clin Immunol. 2000;106(5):840–843. doi:10.1067/mai.2000.110468.; Roy SR, Sigmon JR, Olivier J, et al. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol. 2007;99(1): 82–86. doi:10.1016/S1081-1206(10)60626-6.; Pfaar O, Demoly P, Gerth van Wijk R, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014;69(7):854–867. doi:10.1111/all.12383.; Вишнева Е.А., Намазова-Баранова Л.С., Алексеева А.А. и др. Аллергенспецифическая иммунотерапия у детей. Стандартизация подходов к оценке эффективности // Педиатрическая фармакология. — 2015. — Т. 12. — № 2. — С. 173–179. [Vishneva EA, Namazova-Baranova LS, Alekseeva AA, et al. Allergenspecific immunotherapy in children. Standardizing the efficacy evaluation approaches. Pediatric pharmacology. 2015;12(2):173–179. (In Russ).] doi:10.15690/pf.v12i2.1280.; Bousquet PJ, Combescure C, Klossek JM, et al. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol. 2009;123(6):1349–1354. doi:10.1016/j.jaci.2009.02.033.; Abramson MJ, Puy RM, Weiner JM. Injection allergen immuno therapy for asthma. Cochrane Database Syst Rev. 2010; (8):CD001186. doi:10.1002/14651858.CD001186.pub2.; Erekosima N, Suarez-Cuervo C, Ramanathan M, et al. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review. Laryngoscope. 2014;124(3):616–627. doi:10.1002/lary.24295.; Mosbech H, Deckelmann R, de Blay F, et al. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2014;134(3):568–575.e7. doi:10.1016/j.jaci.2014.03.019.; Marogna M, Braidi C, Bruno ME, et al. The contribution of sublingual immunotherapy to the achievement of control in birchrelated mild persistent asthma: a real-life randomised trial. Allergol Immunopathol (Madr). 2013;41(4):216–224. doi:10.1016/j.aller.2012.07.004.; Penagos M, Passalacqua G, Compalati E, et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest. 2008;133(3):599–609. doi:10.1378/chest.06-1425.; Tam HH, Calderon MA, Manikam L, et al. Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review. Allergy. 2016;71(9):1345–1356. doi:10.1111/all.12932.; Вишнева Е.А., Намазова-Баранова Л.С. Аллерген специ фическая иммунотерапия у детей: перспективы профилактики и лечения // Педиатрическая фармакология. — 2015. — Т. 12. — № 5. — С. 532–536. [Vishnyova EA, Namazova-Baranova LS. Allergen-specific immunotherapy in children: prospects of prevention and treatment. Pediatric pharmacology. 2015;12(5):532–536. (In Russ).] doi:10.15690/pf.v12i5.1454.; Dhami S, Nurmatov U, Halken S, et al. Allergen immunotherapy for the prevention of allergic disease: protocol for a systematic review. Pediatr Allergy Immunol. 2016;27(3):236–241. doi:10.1111/pai.12524.; https://www.pedpharma.ru/jour/article/view/1450
-
2Academic Journal
Authors: ВИШНЁВА ЕЛЕНА АЛЕКСАНДРОВНА, НАМАЗОВА-БАРАНОВА Л.С., АЛЕКСЕЕВА А.А., СЕЛИМЗЯНОВА Л.Р., ЛЕВИНА Ю.Г., ЭФЕНДИЕВА К.Е., ДОБРЫНИНА Е.А.
File Description: text/html
-
3Academic Journal
Source: Педиатрическая фармакология.
Subject Terms: АЛЛЕРГЕНСПЕЦИФИЧЕСКАЯ ИММУНОТЕРАПИЯ,СУБЛИНГВАЛЬНАЯ АЛЛЕРГЕНСПЕЦИФИЧЕСКАЯ ИММУНОТЕРАПИЯ,ПАТОГЕНЕТИЧЕСКАЯ ТЕРАПИЯ АЛЛЕРГИИ,ИНДУКЦИЯ ИММУННОЙ ТОЛЕРАНТНОСТИ,ДЕТИ,ALLERGEN IMMUNOTHERAPY SUBLINGUAL ALLERGEN IMMUNOTHERAPY,ALLERGY PATHOGENETIC THERAPY,IMMUNE TOLERANCE INDUCTION AND CHILDREN, 3. Good health
File Description: text/html
